Customized Supplier for Ginseng stems and leaves Extract to Slovakia Factory
Customized Supplier for Ginseng stems and leaves Extract to Slovakia Factory Detail:
Product detail pictures:
We've our have sales staff, style and design staff, technical crew, QC team and package workforce. We've strict excellent control procedures for each system. Also, all of our workers are experienced in printing field for Customized Supplier for Ginseng stems and leaves Extract to Slovakia Factory, The product will supply to all over the world, such as: Hongkong , Argentina , Uzbekistan , We believe that good business relationships will lead to mutual benefits and improvement for both parties. We've got established long-term and successful cooperative relationships with many customers through their confidence in our customized services and integrity in doing business. We also enjoy a high reputation through our good performance. Better performance is going to be expected as our principle of integrity. Devotion and Steadiness will remain as ever.
Watch our Training Webinar titled “A tough time to fight: The struggle of T-Cell immunity following transplantation” presented by Dr Jean-Sébastien Delisle from the Université de Montréal and the CNTRP.
The objectives of the talk are:
- Understand how the various components of the immune system recognize pathogens
- Recognize the principal virus-related complications in transplantation
- Understand the current and emerging approaches to enhance immunoreconstitution post-transplant
To learn more about organ donation and transplantation research, and watch other webinars, visit www.cntrp.ca – Follow us on twitter @CNTRP – www.twitter.com/cntrp
SPEAKER: Jean-Sébastien Delisle is a transplant hematologist who completed a PhD in transplantation immunology. Since 2010, he works as staff hematologist and principal investigator at Maisonneuve-Rosemont Hospital and is an assistant-professor at the Université de Montréal. His lab focusses on basic and translational T-cell biology. Specifically, Dr Delisle works on the signals and mechanisms that dictate T-cell differentiation and memory/effector development. These studies feed an active translational program in clinical adoptive immunotherapy where Dr Delisle devises and implements clinical-grade ex vivo culture sytems to generate cellular immunotherapy products. He currently supervises or co-supervises two T-cell adoptive immunotherapy clinical studies directly derived from his work. Dr. Delisle is the Co-Lead of the CNTRP Project 5: Predicting and controlling viral complications of transplantation